###begin article-title 0
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT
###end article-title 0
###begin p 1
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 336 337 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 371 372 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1079 1080 1075 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1219 1220 1215 1216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1269 1274 1265 1270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 1274 1277 1270 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 1326 1327 1322 1323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1264 1267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The HIV-1 accessory protein viral protein R (Vpr) causes G2 arrest and apoptosis in infected cells. We previously identified the DNA damage-signaling protein ATR as the cellular factor that mediates Vpr-induced G2 arrest and apoptosis. Here, we examine the mechanism of induction of apoptosis by Vpr and how it relates to induction of G2 arrest. We find that entry into G2 is a requirement for Vpr to induce apoptosis. We investigated the role of the mitochondrial permeability transition pore by knockdown of its essential component, the adenine nucleotide translocator. We found that Vpr-induced apoptosis was unaffected by knockdown of ANT. Instead, apoptosis is triggered through a different mitochondrial pore protein, Bax. In support of the idea that checkpoint activation and apoptosis induction are functionally linked, we show that Bax activation by Vpr was ablated when ATR or GADD45alpha was knocked down. Certain mutants of Vpr, such as R77Q and I74A, identified in long-term nonprogressors, have been proposed to inefficiently induce apoptosis while activating the G2 checkpoint in a normal manner. We tested the in vitro phenotypes of these mutants and found that their abilities to induce apoptosis and G2 arrest are indistinguishable from those of HIV-1NL4-3vpr, providing additional support to the idea that G2 arrest and apoptosis induction are mechanistically linked.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 364 365 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 502 505 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 917 920 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 1009 1010 1009 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1481 1485 1481 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr.</italic>
###xml 1563 1566 1563 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 217 222 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1475 1480 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1587 1592 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 encodes a small gene known as vpr (viral protein regulatory) whose product is a 96-amino acid protein. HIV-1 infects cells of the immune system, such as CD4-positive lymphocytes. When cells become infected with HIV-1, two deleterious effects result from expression of the vpr gene. One effect of vpr is to manipulate the cell cycle by blocking the cells in G2 (the phase of the cell cycle immediately preceding mitosis). Thus, cells infected with HIV-1 cease to proliferate, due to the action of vpr. A second effect of vpr is the induction of cell death by a process known as apoptosis or programmed cell death. When cells die by apoptosis, they do so following activation of a cellular set of genes and proteins whose primary function is to inactivate various cellular functions that are needed in order to maintain cellular viability. In this study, Andersen et al. demonstrate that the above two effects of vpr are linked. In particular, the authors show that the blockade in cell proliferation in G2 is a requirement toward the onset of programmed cell death. Programmed cell death can be accomplished by a number of cellular proteins known as "executioners." Various executioner proteins reside on the mitochondrial membranes and may trigger release of factors from the mitochondria, which in turn will precipitate the onset of apoptosis. In this work Anderson et al. identify the mitochondrial protein, Bax, as the key executioner of apoptosis in the context of HIV-1 vpr. The authors' findings provide important mechanistic understanding of how the vpr gene contributes to HIV-1-induced cell death.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b001">1</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b003">3</xref>
###xml 558 559 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b004">4</xref>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b006">6</xref>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b007">7</xref>
###xml 731 732 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 812 817 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 912 917 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Loss of CD4+ lymphocytes is a hallmark of progression to acquired immune deficiency syndrome (AIDS). The mechanisms proposed to explain the loss and dysfunction of CD4+ T cells are multiple and include indirect effects of viral infection, such as generalized activation of the immune system, CD8+ cytotoxic T lymphocyte-mediated killing of infected cells, as well as direct effects of infection such as virus budding, and expression of certain viral genes (reviewed in [1-3]). Analysis of virus dynamics in vivo has revealed that a significant portion of CD4+ T-cell death is due to virus-induced cytotoxicity in the infected cells [4-6], and the estimated half-life of infected lymphocytes is on the order of 2 d (reviewed in [7]). Therefore, studies that seek to understand the molecular and cellular basis of HIV-1-induced death in T cells are critical toward explaining how immune deterioration results from HIV-1 infection.
###end p 5
###begin p 6
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b008">8</xref>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b009">9</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b010">10</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b011">11</xref>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 viral protein R (Vpr) has emerged as a major proapoptotic gene product (reviewed in [8,9]). In an effort to characterize the apoptotic signaling cascade induced by Vpr downstream of the mitochondria, Muthumani et al. [10,11] demonstrated that Vpr induces apoptosis via the intrinsic pathway. This pathway is characterized by cytochrome c release and caspase 9 activation and is triggered in the absence of death receptor ligation.
###end p 6
###begin p 7
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b012">12</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 394 395 394 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b016">16</xref>
Vpr induces a second type of cytopathic effect by blocking the cell cycle in the G2 phase. We, and others, have previously shown that Vpr causes activation of the G2 checkpoint protein, ATR (ataxia and telangiectasia mutated and Rad3 related), a serine/threonine kinase responsive to DNA damage and replication stress [12-14]. Furthermore, activation of ATR by Vpr is required for Vpr-induced G2 arrest and involves the ATR-associated molecules Rad17 and the Rad9-Rad1-Hus1 trimer [14-16].
###end p 7
###begin p 8
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b018">18</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b019">19</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b020">20</xref>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b012">12</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
A cause-effect relationship between the two deleterious actions of Vpr (G2 arrest and apoptosis) has not been established. Indirect evidence supports the notion that induction of G2 arrest and apoptosis are linked. For example, treatment of cells with either caffeine, an inhibitor of ATR/ATM checkpoint function, or small interfering RNA (siRNA) specific to ATR, relieves both Vpr-induced G2 arrest and apoptosis [17,18]. In addition, Yuan et al. [19,20] demonstrated that siRNA knockdown of Wee1, a Cdk1 inhibitor that is activated by DNA damage, abrogated both Vpr-induced G2 arrest and apoptosis. Taken together, these data suggest a model in which checkpoint activation and apoptosis signaling by Vpr are functionally associated and that such an association stems from the ability of Vpr to activate ATR [12-14,17].
###end p 8
###begin p 9
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b021">21</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b022">22</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b023">23</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b024">24</xref>
###xml 577 578 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
On the other hand, evidence from mutagenesis studies suggests that checkpoint activation and apoptosis may be separable effects of Vpr. Thus, mutants of Vpr have been described that induce normal levels of G2 arrest but are partially impaired for induction of apoptosis [21,22]. One model to explain the proapoptotic activity of Vpr was proposed by Jacotot et al. [23] and Vieira et al. [24], who observed that recombinant Vpr associates with the adenine nucleotide transporter (ANT) on purified mitochondria, to directly promote release of mitochondrion-associated cytochrome c and apoptosis. This finding suggested that Vpr initiated the commitment to apoptosis at the mitochondrial membrane by binding to ANT, rather than by activating upstream stress signaling pathways derived from checkpoint activation.
###end p 9
###begin p 10
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 137 138 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 223 224 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In the present study, we examine the relationship between induction of G2 arrest and onset of apoptosis by Vpr. We find that entry into G2 is a requirement for Vpr to induce apoptosis. Since the requirement for entry into G2 seemed inconsistent with the reported ability of Vpr to bind to ANT and promote apoptosis in a cell cycle-independent manner, we then examined the requirement for ANT. We find that Vpr-induced apoptosis is unaffected by knockdown of ANT. Instead, Vpr-induced apoptosis is dependent on the presence of Bax and is concomitant with Bax activation. Furthermore, Bax activation is a result of proapoptotic signals transduced by Vpr through the upstream stress proteins ATR and GADD45alpha (growth arrest and DNA damage-responsive protein alpha) because knockdown of ATR or GADD45alpha prevented activation of Bax. We also demonstrate that, despite the striking similarities between the signaling events induced by Vpr and those induced by genotoxic stress, important differences can be found. Specifically, Vpr-induced apoptosis is abrogated by checkpoint inhibition, while apoptosis induced by genotoxic agents is exacerbated by checkpoint inhibition. Taken together, these results demonstrate that Vpr activates the ATR-initiated DNA damage-signaling pathway to link checkpoint activation and commitment to apoptosis.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
G2 Arrest Precedes the Release of Mitochondrial Smac and Caspase Activation
###end title 12
###begin p 13
###xml 103 104 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b018">18</xref>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b023">23</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b024">24</xref>
Treatment with caffeine, an inhibitor of ATR and ATM, or siRNA targeted to ATR, abrogates Vpr-induced G2 arrest and apoptosis [14,17,18]. One possible explanation for these observations would be that Vpr induces apoptosis as a downstream consequence of sustained G2 checkpoint activation. This idea, however, is inconsistent with a previously published model in which Vpr was proposed to directly bind to the mitochondrial ANT to cause release of proapoptotic factors in a cell cycle-independent manner [23,24].
###end p 13
###begin p 14
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 712 720 712 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 1041 1042 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b025">25</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b027">27</xref>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b013">13</xref>
###xml 1130 1132 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 1133 1135 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b026">26</xref>
###xml 1252 1257 1252 1257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 1266 1274 1266 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 454 459 <span type="species:ncbi:9606">human</span>
###xml 1247 1250 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To begin to differentiate between these models, we studied the kinetics of induction of G2 arrest and apoptosis. If apoptosis were a consequence of G2 checkpoint signaling, we would predict that G2 arrest should precede the onset of apoptosis. However, if Vpr were binding ANT to induce apoptosis, we would predict that commitment to apoptosis should be independent of cell cycle status and would occur early following expression of Vpr. We transduced a human CD4+ T-lymphocyte cell line, SupT1, with lentiviral vectors (pHR-VPR-G or pHR-VPR-R) expressing Vpr and either green fluorescent protein (GFP) or monomeric red fluorescent protein (mRFP), respectively, with an intervening internal ribosome entry site (Figure 1A). Having essentially identical vectors with different fluorescent tags allowed us to stain infected cells with a variety of fluorescent indicators of cell cycle profile and apoptosis. As a control, we used isogenic vectors expressing a mutant form of Vpr, pHR-VPR(R80A), wherein Vpr(R80A) is defective in induction of G2 arrest and apoptosis [17,25-27]. These vectors were previously described in detail [13,17,26]. In parallel experiments, we transduced SupT1 cells with VSV-G pseudotyped, env-defective vector derived from HIV-1NL4-3 (DHIV3; Figure 1A) or a mutant form of the previous vector with Vpr deleted (DHIV3-DeltaVPR). At various time points, cultures were harvested and partitioned for further analyses. Analyses included cell cycle profile, induction of apoptosis as measured by caspase activation, and Western blot to detect release of Smac (second mitochondria-derived activator of caspase) into the cytoplasm.
###end p 14
###begin p 15
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 150 158 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 315 323 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 344 352 344 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 473 481 473 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
Accumulation of Vpr-expressing cells at G2 began at 24 h post-transduction, peaked at 48 h, and persisted throughout the remainder of the experiment (Figure 1B). In contrast, caspase activation in Vpr-expressing cells was first detected at 36 h and continued to increase throughout the remainder of the experiment (Figure 1C). Release of Smac (Figure 1D) also occurred late, between 72 and 96 h post-transduction. Samples of flow cytometry charts from experiments shown in Figure 1C at the 72-h time point are presented in Figure 1E.
###end p 15
###begin p 16
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Therefore, induction of G2 arrest is an early Vpr-mediated event, whereas release of Smac and caspase activation lag in relation to cell cycle arrest by approximately 24 h. Since G2 arrest clearly precedes apoptosis, we found it compelling to ask whether transition into G2 was required for the commitment to apoptosis in Vpr-expressing cells.
###end p 16
###begin title 17
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
G1/S Block Abolishes the Induction of Apoptosis by Vpr
###end title 17
###begin p 18
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b028">28</xref>
###xml 553 554 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 568 570 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 571 573 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 574 576 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b026">26</xref>
###xml 577 579 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b029">29</xref>
###xml 697 698 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 711 713 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b028">28</xref>
###xml 815 816 811 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 820 828 816 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 914 915 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 938 939 934 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 986 987 982 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1071 1072 1067 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1522 1524 1518 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 1525 1527 1521 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b030">30</xref>
###xml 1530 1538 1526 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 1633 1641 1629 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 1826 1834 1822 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 544 549 <span type="species:ncbi:9606">human</span>
We designed an experiment to prevent Vpr-expressing cells from entering G2 and then asked whether these cells would still be susceptible to Vpr-induced apoptosis. We chose to perform the experiment in HeLa cells since these cells can be synchronized by incubation with 2 mM thymidine with minimal toxicity [28]. HeLa cells represent an appropriate cell type to study Vpr-induced apoptosis, because ATR activation, breast cancer-associated protein 1 (BRCA1) phosphorylation, and GADD45alpha upregulation are conserved from HeLa cells to primary human CD4+ lymphocytes [14,17,26,29]. HeLa cells were transduced with pHR-VPR-G and, 4 h later, treated with 2 mM thymidine, which arrests cells at the G1/S boundary [28]. DNA content analysis showed that thymidine treatment effectively synchronized uninfected cells in G1/S (Figure 2A). Thymidine synchronization of pHR-VPR-G-infected cells resulted in 82.9% cells in G1/S and 17.0% cells in G2/M. The comparatively high number of cells in G2/M in the synchronized, pHR-VPR-infected culture (17%) reflects cells that reached G2/M prior to synchronization and arrested due to Vpr expression. To evaluate the frequency of apoptotic cells in these cultures, cells were stained with the nuclear dye 4',6-diamidino-2-phenylindole dihydrochloride (DAPI). DAPI binds to chromatin and reveals the presence of a conspicuous pyknotic nuclear morphology that is associated with late stages of apoptosis. We have previously described the use of DAPI for analysis of Vpr-induced apoptosis [17,30]. Figure 2B shows fluorescence microscopy photographs from this analysis, and quantitations are shown in Figure 2C. DAPI staining revealed that at 48 h post-transduction, 23% of cells transduced with Vpr were apoptotic if allowed to cycle, whereas only 7% were apoptotic if treated with thymidine (Figure 2C). The background level of apoptosis in uninfected cells treated with thymidine was 4%.
###end p 18
###begin p 19
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 499 500 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b031">31</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b032">32</xref>
###xml 598 599 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 630 638 630 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
To address whether the decreased sensitivity of G1/S-arrested cells to Vpr-induced apoptosis could be due to thymidine treatment itself, cells were treated with a pharmacologic apoptosis inducer (etoposide or staurosporine) and then allowed to cycle, or not (thymidine incubation). Staurosporine is a kinase inhibitor and potent inducer of apoptosis with no known cell cycle specificity. Etoposide is a topoisomerase II inhibitor and an inducer of double-strand breaks (DSBs) and, like Vpr, causes G2 arrest [31,32]. Treatment with staurosporine or etoposide effectively induced apoptosis in both G1/S-arrested and cycling cells (Figure 2C).
###end p 19
###begin p 20
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
###xml 467 468 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
To confirm the previous apoptosis results, we performed parallel experiments using pHR-VPR-R and staining for caspase activity with FITC-VAD-FMK (Figure 2D) and by measuring poly-ADP-ribose polymerase (PARP) cleavage (Figure 2E). Analysis of Vpr expression by Western blot revealed that thymidine treatment did not affect expression of Vpr (Figure 2F). These results are in agreement with those obtained by DAPI staining and confirm that synchronization of cells in G1/S alleviates Vpr-induced apoptosis.
###end p 20
###begin title 21
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Release of Vpr-Expressing Cells from G1/S Block Leads to G2 Arrest-Dependent Apoptosis
###end title 21
###begin p 22
###xml 117 118 117 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 466 474 466 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 530 531 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 652 660 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 719 720 719 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 758 766 758 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 855 856 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The previous results indicate that the proapoptotic effect of Vpr is lost when cells are artificially maintained in G1/S. To determine whether induction of apoptosis by Vpr specifically requires transition into G2, cells were synchronized as in the previous experiment and then were released from thymidine block and allowed to reenter the cell cycle. Released cells were harvested at specified intervals to examine cell cycle progression (Figure 3A) and apoptosis (Figure 3B). Both mock-treated and Vpr-expressing cells entered G2 at 12 h postrelease. Mock-infected cells completed the first division cycle at 18 h postrelease and continued to cycle (Figure 3A, upper panels), while cells expressing Vpr persisted in G2 for the remainder of the experiment (Figure 3A, lower panels). A small amount of cells (17.4%) in the Vpr-transduced culture reached G1 at 18 h postrelease. The reason for this is that the efficiency of transduction with pHR-VPR was about 80% and therefore about 20% are untransduced.
###end p 22
###begin p 23
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 181 189 181 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 266 274 266 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 380 381 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 427 428 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 430 438 430 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
We then asked when, after release from the thymidine block, Vpr-expressing cells would enter apoptosis. Cells which were synchronized, maintained in G1 for 48 h, and then released (Figure 3B, lanes 2-6) began to display detectable PARP cleavage by 12 h postrelease (Figure 3B, lane 3). Therefore, the onset of apoptosis in Vpr-expressing cells is concomitant with entry into the G2 phase. In the absence of synchronization in G1 (Figure 3B, lanes 7-11), Vpr-expressing cells begin to display PARP cleavage by 24 h post-transduction. Synchronized cells, in the absence of Vpr expression, did not display PARP cleavage after release (unpublished data).
###end p 23
###begin p 24
###xml 99 107 99 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g003">Figure 3</xref>
Parallel samples from the previous synchronization experiment were also analyzed by DAPI staining (Figure 3C). These experiments revealed chromatin fragmentation/condensation in Vpr-expressing cells at 24 and 48 h postrelease (Figure 3C).
###end p 24
###begin p 25
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Taken together, these data indicate that Vpr-induced apoptosis requires entry into the G2 phase and artificially maintaining cells in G1 effectively prevents the onset of apoptosis.
###end p 25
###begin title 26
Inhibition of ATR Prevents Vpr-Induced Apoptosis but Exacerbates Genotoxin-Induced Apoptosis
###end title 26
###begin p 27
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b012">12</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b033">33</xref>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b034">34</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b037">37</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b035">35</xref>
###xml 998 999 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1007 1008 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1016 1017 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1089 1090 1088 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1225 1233 1223 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
###xml 1239 1240 1237 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">4</xref>
###xml 1818 1826 1816 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
###xml 1961 1969 1959 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
Due to the phenotypic similarities between Vpr and genotoxic stress, many studies on Vpr have been modeled based on the current understanding of DNA damage signaling [12,14,33]. Several reports have shown that suppression of G2 checkpoint-activating kinases after exposure to genotoxic agents overrides cell cycle arrest but exacerbates apoptosis [34-37]. The reason for this increase in cell death is thought to be the inability of cells to successfully duplicate DNA or to align and segregate damaged chromosomes during mitosis (reviewed in [35]). Thus, we set out to compare in parallel the effect of ATR suppression on Vpr- versus genotoxin-induced apoptosis. We reasoned that if Vpr causes irreparable DNA damage, then the effect of checkpoint overriding on Vpr-induced apoptosis should mirror that of cells treated with genotoxic agents. To test this, we treated cells with siRNAs specific to ATR, ATM, or nonspecific siRNA. At 48 h following siRNA transfection, we treated cells with 25 muM N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), an SN1-type methylating agent and inducer of G2 arrest, or 25 muM etoposide. At 24- and 48-h time points following the addition of etoposide or MNNG, we measured caspase activation (Figure 4A and 4B; for simplicity, only one time point is shown in 4A). Knockdown of ATR dramatically exacerbated etoposide- and MNNG-induced apoptosis (14.5% to 60.7% and 6.2% to 35.4%, respectively, at 48 h). Knockdown of ATM led to a modest increase in genotoxin-induced apoptosis (14.5% to 21.3% for etoposide and 6.2% to 10% for MNNG, at 48 h). In contrast, Vpr-induced caspase activation was dramatically inhibited by ATR knockdown (from 41.2% to 14.2%) but was unaffected by ATM knockdown (41.2% to 39.4%). DAPI staining showed a similar ATR-dependent decrease in Vpr-induced apoptosis (Figure 4C). The level of knockdown achieved by each siRNA was determined by Western blot with antibodies specific for the endogenous proteins (Figure 4D).
###end p 27
###begin p 28
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
In conclusion, we demonstrated the requirement for ATR checkpoint activation through two different methodologies: (a) manipulation by G1/S synchronization and (b) ATR knockdown. We also conclude that this aspect of Vpr function represents a departure from the manner in which checkpoint activation relates to apoptosis in the context of genotoxic agents.
###end p 28
###begin title 29
Vpr-Induced Apoptosis Does Not Require ANT but Is Mediated via Bax, Downstream of ATR Activation
###end title 29
###begin p 30
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b038">38</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b023">23</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b039">39</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b042">42</xref>
###xml 591 593 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b039">39</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b040">40</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b042">42</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b043">43</xref>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b044">44</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b045">45</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b043">43</xref>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b046">46</xref>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b048">48</xref>
###xml 406 411 <span type="species:ncbi:10090">mouse</span>
###xml 600 605 <span type="species:ncbi:10090">Mouse</span>
Early reports suggested that the permeability transition pore complex (PTPC), which consists of VDAC, ANT, and cyclophilin D, was involved in release of apoptotic factors from the mitochondria in response to various apoptotic stimuli (reviewed in [38]) and, in particular, for Vpr [23]. However, later reports have put in question the role of the PTPC in DNA damage-induced apoptosis [39-42]. For example, mouse cells deficient in ANT are fully capable of undergoing apoptosis in response to DNA damage and, instead, show increased resistance to necrosis in response to high intracellular Ca2+ [39]. Mouse cells deficient in cyclophilin D, which is required for VDAC function, are fully capable of undergoing apoptosis in response to genotoxins [40,42]. Large oligomeric complexes containing Bax and possessing apoptotic pore function do not contain ANT or VDAC [43]. Bax is required for activation of the mitochondrial pore-forming complex that responds to DNA damage (reviewed in [44,45]) and the pore-forming function of Bax is independent of ANT or VDAC [43,46-48].
###end p 30
###begin p 31
###xml 386 394 386 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
###xml 480 488 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
###xml 562 570 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
###xml 634 642 634 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
Thus, we asked whether Vpr-induced apoptosis is mediated through ANT or, alternatively, through Bax. We addressed this question using siRNAs that would specifically downregulate Bax or ANT, in the context of pHR-VPR-R transduction. Bax knockdown led to a dramatic decrease in Vpr-induced apoptosis (from 41.2% in the presence of nonspecific siRNA to 12.6% in the presence of Bax siRNA; Figure 4A), whereas ANT knockdown had no appreciable effect on apoptosis (41.2% versus 39.5%; Figure 4A). These results were also confirmed by analysis of DAPI-stained nuclei (Figure 4C). The levels of knockdown achieved by each siRNA are shown in Figure 4D.
###end p 31
###begin p 32
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b049">49</xref>
###xml 292 293 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 477 485 473 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
Activation of Bax is associated with a conformational change that exposes an N- terminal epitope detected by monoclonal antibody Bax6A7 [49]. Thus, reactivity with Bax6A7 provides a direct measurement of Bax activation. To probe for Bax activation in the presence of Vpr, peripheral blood CD4+ lymphocytes were infected with either DHIV3 or DHIV3-DeltaVPR, cells were lysed, and immunoreactivity with Bax6A7 antibody was tested by immunoprecipitation followed by Western blot (Figure 4E). Reactivity with Bax6A7 was increased following infection with DHIV3, when compared with that of mock- or DHIV3-DeltaVPR-infected cells.
###end p 32
###begin p 33
###xml 199 201 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b014">14</xref>
###xml 202 204 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 837 845 821 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g004">Figure 4</xref>
###xml 1001 1002 985 986 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Our previous studies established that Vpr-induced ATR activation leads to BRCA1 phosphorylation and GADD45alpha upregulation and that both ATR and GADD45alpha are required for Vpr-induced apoptosis [14,17]. Based on previous findings and data reported here, we propose that ATR activation is an upstream signaling event in the pathway leading to Vpr-induced cell cycle arrest and apoptosis. If this were correct, then it would follow that Bax activation by Vpr is also ATR dependent. In order to examine the requirement of ATR in Vpr-induced Bax activation, we treated cells with siRNAs specific to either ATR or GADD45alpha prior to transduction with pHR-VPR-R. We observed that the increase in Bax6A7 reactivity was reduced to basal levels in the presence of either ATR or GADD45alpha knockdown but not when using a nonspecific siRNA (Figure 4F). Therefore, these results provide additional support for a model in which Bax activation is a principal effector of Vpr-induced apoptosis downstream of G2 checkpoint activation by the ATR kinase.
###end p 33
###begin title 34
Effect of Vpr on Mitotic Entry
###end title 34
###begin p 35
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b050">50</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b053">53</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b054">54</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b055">55</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b056">56</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b057">57</xref>
###xml 608 616 608 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g005">Figure 5</xref>
###xml 851 852 851 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1262 1263 1262 1263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1302 1303 1302 1303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
It is unclear whether cells arrested in G2 by Vpr transition into mitosis. Early measurements of the mitotic index suggested that Vpr induced G2 arrest and concomitantly inhibited entry into mitosis [50-53]. Later studies, however, showed that cells expressing Vpr develop mitotic abnormalities such as multipolar spindles, mislocalization of certain spindle pole body proteins, and defects in cytokinesis [54,55], collectively indicating mitotic entry. To reexamine the issue of mitotic entry in the context of Vpr, we measured phosphorylation of histone 3 (H3) at serine-10 [56,57] in the presence of Vpr (Figure 5). As positive and negative controls, we incubated cells with nocodazole (lanes 2 and 6) and doxorubicin (lanes 3 and 7), respectively. Doxorubicin is a genotoxic agent that intercalates into DNA, inhibits topoisomerase 2 and induces G2 arrest via Cdc2 Tyr15 phosphorylation, without allowing mitotic entry. Nocodazole arrests cells in mitosis and exerts its effect by depolymerizing microtubules. HeLa cells transduced with pHR-VPR displayed a high level of H3 phosphorylation (lane 4), whereas transduced SupT1 cells displayed no detectable H3 phosphorylation (lane 8). Therefore, Vpr expression leads to mitotic entry in HeLa cells following G2 arrest, whereas Vpr causes sustained G2 arrest in SupT1 cells without subsequent mitotic entry.
###end p 35
###begin title 36
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Analysis of G2 Arrest and Apoptosis Induction by Clinically Relevant Vpr Alleles and by a Vpr-GFP Fusion Chimera
###end title 36
###begin p 37
###xml 114 115 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b022">22</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b021">21</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b058">58</xref>
###xml 647 648 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 762 763 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b059">59</xref>
###xml 880 881 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1062 1070 1062 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figure 1</xref>
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Several natural or laboratory-constructed mutants of HIV-1 Vpr have been reported that selectively ablate either G2 arrest or apoptosis. These mutants can be categorized into two groups. The first group includes vpr alleles with amino acid substitutions that have been observed in long-term nonprogressors, with a reduced ability to cause apoptosis but with normal induction of G2 arrest. These substitutions include Q3R [22], R77Q [21], and I47A [58]. The second group includes Vpr-GFP and GFP-Vpr fusion proteins. In particular, it was reported that while a GFP-Vpr (whereby Vpr is carboxyl-terminal to GFP) fusion protein was inactive in both G2 arrest and apoptosis induction, the reciprocal chimera, Vpr-GFP, was able to induce apoptosis in the absence of G2 arrest [59]. Collectively, the data obtained with both groups of mutants would appear to support that induction of G2 arrest and apoptosis are independent, separable functions of Vpr. We wished to examine the phenotype of these mutants and chimeras using the experimental paradigms we described in Figure 1.
###end p 37
###begin p 38
###xml 111 116 111 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 286 294 286 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g006">Figure 6</xref>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 529 530 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 641 642 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 694 695 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 704 705 704 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 752 753 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 809 810 809 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 844 845 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 106 109 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The Vpr mutants, R77Q and I74A, were separately constructed in the background of pHR-VPR-R (which encodes HIV-1NL4-3vpr). Lentiviral vectors were then produced and used to infect target cells. Transduced cells were then evaluated for cell cycle stage at 48 h and for apoptosis at 72 h (Figure 6A). The levels of apoptosis, as judged by staining with FITC-VAD-FMK, were very similar between wild-type Vpr, Vpr(R77Q), and Vpr(I74A) and the levels of G2 arrest were also similar. To more directly assess whether the frequencies of G2 arrest and apoptosis correlated with each other, we calculated the ratio of cells in apoptosis over cells in G2 for each mutant Vpr (% apoptotic cells/% cells in G2/M [Apo/G2M]). If a Vpr mutant induces normal levels of G2 arrest, but reduced levels of apoptosis, then the Apo/G2M ratio should decrease. The Apo/G2M ratios were 0.83 for wild-type Vpr, 0.91 for Vpr(R77Q), and 0.92 for Vpr(I74A). Therefore, we conclude that neither of the Vpr mutants tested here resulted in lower levels of apoptosis induction, when compared to wild-type Vpr.
###end p 38
###begin p 39
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 514 522 514 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g006">Figure 6</xref>
We previously demonstrated that Vpr induced phosphorylation BRCA1 at residue Ser1423 by the ATR kinase and that this phosphorylation correlated with induction of apoptosis [17]. To examine whether the Vpr mutants had a normal ability to induce BRCA1 phosphorylation, we performed Western blot on lysates from cells infected with the above lentiviral vectors. Wild-type Vpr and mutants were able to induce BRCA1 phosphorylation, and this phosphorylation was, in all three cases, ablated by treatment with caffeine (Figure 6B). Therefore, we were unable to find any detectable differences in the functions of Vpr(R77Q) or Vpr(I74A) when compared with Vpr(R77).
###end p 39
###begin p 40
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b025">25</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b025">25</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b059">59</xref>
###xml 393 394 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b059">59</xref>
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 887 895 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g006">Figure 6</xref>
###xml 1033 1042 1033 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g001">Figures 1</xref>
###xml 1047 1048 1047 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">2</xref>
We then examined the phenotype of a Vpr-GFP fusion protein. It is well known that the addition of recombinant amino acid sequences as small as the influenza hemagglutinin tag at the carboxyl terminus of Vpr results in failure of Vpr to activate the G2 checkpoint [25]. Carboxyl-terminal addition of larger fusion partners, such as luciferase [25] or GFP [59], also results in ablation of the G2 arrest. Waldhuber et al. [59] found that carboxyl-terminal addition of GFP resulted in a Vpr chimera that was fully able to induce apoptosis. We constructed a Vpr-GFP chimera and observed that it was, as expected, unable to induce G2 arrest (unpublished data). We then examined the induction of apoptosis by the fusion protein. To generate an appropriate control, we introduced the R80A mutation in the fusion construct, to generate Vpr(R80A)-GFP, and tested its ability to induce apoptosis (Figure 6C). Both Vpr-GFP and Vpr(R80A)-GFP were able to induce apoptosis. Since Vpr(R80A) that is not fused to GFP is unable to induce apoptosis (Figures 1 and 2), we expected that the introduction of the R80A substitution in the Vpr-GFP fusion protein [Vpr(R80A)-GFP] would also result in a protein devoid of apoptosis induction. Surprisingly, Vpr(R80A)-GFP is also capable of inducing apoptosis. Because the fusion with carboxyl-terminal GFP turns Vpr(R80A), a nonproaptotic protein, into an apoptotic one, it appears that the induction of apoptosis by Vpr-GFP represents a gain-of-function phenotype and is not representative of the biology of wild-type Vpr.
###end p 40
###begin p 41
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In conclusion, our results suggest that induction of G2 arrest and apoptosis by HIV-1 Vpr are functionally interrelated and not genetically separable.
###end p 41
###begin title 42
Discussion
###end title 42
###begin title 43
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The Functional Relationship between G2 Arrest and Apoptosis
###end title 43
###begin p 44
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b060">60</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b061">61</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b062">62</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b063">63</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b030">30</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b064">64</xref>
###xml 1062 1063 1062 1063 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1065 1073 1065 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g007">Figure 7</xref>
One gap in our current understanding of checkpoint signaling and apoptosis lies between the activation of nuclear checkpoint sentinels, such as ATR and ATM, and the involvement of Bcl-2 family of apoptosis regulators at the mitochondria. Previous reports have suggested that nuclear proteins, such as Rad9 or Histone H1, may translocate from the nucleus to the cytoplasm in response to DNA damage, to interact with mitochondrion-associated Bcl-2 family proteins and promote cytochrome c release and apoptosis [60,61]. In other instances of DNA damage, activated p53 was shown to directly promote Bax activation [62,63]. However, loss of p53 does not abrogate induction of apoptosis by Vpr [30,64], and we have been unable to observe Rad9 or histone H1 translocation to the mitochondria in response to Vpr (J. L. Andersen and V. Planelles, unpublished data). These observations, taken together with the results presented here, indicate that Vpr links checkpoint activation and apoptosis in a novel manner and that a key element is the requirement for entry into G2 (Figure 7A).
###end p 44
###begin p 45
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b020">20</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b019">19</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b020">20</xref>
###xml 343 344 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b019">19</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b020">20</xref>
###xml 499 500 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In support of a cause-effect relationship between Vpr-induced G2 arrest and apoptosis, several reports demonstrate that the apoptotic effect of Vpr can be overridden by suppressing G2-specific cell cycle-regulating kinases [17-20]. Yuan et al. [19,20] found that Wee1, a kinase which negatively regulates Cdk1 activity and thus regulates the G2-to-M transition, is activated by Vpr. Furthermore, Yuan et al. [19,20] showed that suppression of Wee1 in the presence of Vpr abrogated both Vpr-induced G2 arrest and apoptosis.
###end p 45
###begin title 46
The Role of ATR in Vpr-Induced Apoptosis Differs from Its Role in Genotoxic Stress-Induced Apoptosis
###end title 46
###begin p 47
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b017">17</xref>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b012">12</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b012">12</xref>
We also demonstrate that ATR knockdown exacerbates genotoxin-induced apoptosis but, surprisingly, relieves Vpr-induced apoptosis [17]. The different effects of ATR knockdown on Vpr- versus genotoxin-induced apoptosis suggest that Vpr activity fundamentally differs from genotoxic stress. More specifically, it is tempting to speculate that such a difference resides in the fact that Vpr does not cause physical DNA damage (such as DSBs) whereas genotoxic agents do. In fact, three lines of evidence indicate that Vpr activates ATR in a manner that does not involve generation of DSBs: (1) Pulse-field gel electrophoresis revealed no DSBs in vpr-expressing cells [12]. (2) Vpr fails to induce phosphorylation of ATM at serine-1981, a residue linked to DSB signaling and potently phosphorylated in response to ionizing radiation [12]. (3) And, as we have shown here, in contrast with etoposide-induced apoptosis, Vpr-induced apoptosis is relieved under conditions of checkpoint suppression.
###end p 47
###begin p 48
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b065">65</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b012">12</xref>
Models for Vpr activity that would be in agreement with the lack of DSB formation by Vpr have been proposed in the past. For example, Vpr may perturb nuclear envelope integrity, as suggested by de Noronha et al. [65]. Perturbation of nuclear envelope integrity may, in turn, lead to ATR activation. In addition, Lai et al. proposed that Vpr binds directly to chromatin in a manner that results in ATR activation [12].
###end p 48
###begin title 49
Role of the Mitochondria in Vpr-Induced Apoptosis
###end title 49
###begin p 50
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b023">23</xref>
###xml 419 427 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g007">Figure 7</xref>
###xml 679 680 679 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 766 767 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 903 904 903 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Previous reports have suggested that Vpr induces apoptosis via a direct interaction with ANT at the inner mitochondrial membrane, which results in release of cytochrome c from fractionated mitochondria [23]. These observations would indicate that Vpr induces mitochondrial depolarization directly, rather than activating upstream stress signals, and suggest that Vpr may induce apoptosis rapidly after being expressed (Figure 7B). We reasoned that if Vpr induced apoptosis by interacting directly with the mitochondria, it would efficiently induce apoptosis regardless of cell cycle status. In contrast with the previous expectation, we observed that cell cycle transition into G2 is required for Vpr to induce apoptosis. Furthermore, blockade of the cell cycle in G1 for 48 h effectively prevented apoptosis, and subsequent release of the block allowed apoptosis induction, coinciding with entry into G2.
###end p 50
###begin p 51
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b023">23</xref>
###xml 661 669 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g007">Figure 7</xref>
Jacotot et al. [23] proposed that the mitochondrial channel activated by Vpr is the PTPC. In sharp contrast, we find that efficient removal of ANT (an essential domain of PTPC) did not affect Vpr apoptosis to any degree. Instead, removal of Bax, an independent mitochondrial pore-forming protein, led to nearly complete suppression of apoptosis. Furthermore, Bax activation is dependent on the presence of ATR, as is induction of apoptosis. Taken together, our data strongly support a model in which the apical step toward Vpr-induced apoptosis is activation of ATR, followed by the activation of downstream apoptotic mediators such as Bax, Smac, and caspases (Figure 7).
###end p 51
###begin title 52
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role of Vpr in HIV-1 Pathogenesis
###end title 52
###begin p 53
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b066">66</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b021">21</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b022">22</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b058">58</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b067">67</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b067">67</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b068">68</xref>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b068">68</xref>
###xml 1612 1614 1612 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b068">68</xref>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
###xml 990 995 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Depletion of CD4+ lymphocytes due to HIV-1 infection leads to immune suppression in AIDS patients (reviewed in [66]). The cause of T-cell depletion in AIDS patients is a question under intense research but remains poorly understood. The discovery of mutations in Vpr that may be associated with long-term nonprogressors and impair the apoptosis-inducing ability of Vpr suggests a critical role for Vpr in AIDS pathology [21,22,58]. However, for the Vpr mutation, R77Q, a recent report has questioned its association with long-term nonprogressors [67]. Fisher et al. [67] proposed that R77Q is associated with certain viral subtypes, such as subtype A, and not with disease progression. A more recent analysis of the GenBank database revealed that R77 predominates in subtype B, whereas Q77 predominates in clades A, C, D, G, and H and groups O and N viruses, and subtype F and K strains frequently encode H77 [68]. Rajan et al. [68] also reported, using isogenic, full-length viruses, that HIV-1 carrying Q77 displayed reduced cytopathicity if the virus had R5 tropism but not if it had X4 tropism. The previous experiments did not uncouple the cytopathic potential of the virus strains from their replication kinetics. Therefore, in our studies, we wished to examine the proapoptotic potential of mutant Vpr proteins in the context of a nonreplicating lentiviral vector and in the absence of other viral genes. Our results conclusively show that in our experimental paradigm, the proapoptotic potentials of Vpr(R77Q) and Vpr(I74A) are indistinguishable from that of Vpr(R77). Thus, the results by Rajan et al. [68] would seem to indicate that the R77Q substitution has a moderate, positive effect on cell viability, and this effect may be related to viral replication efficiency rather than to proapoptotic signaling.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
Western blotting procedures.
###end title 55
###begin p 56
###xml 109 115 <span type="species:ncbi:9913">bovine</span>
###xml 784 790 <span type="species:ncbi:9986">rabbit</span>
###xml 957 963 <span type="species:ncbi:9986">rabbit</span>
For PARP and HA-Vpr detection, cells were detached with trypsin, washed once with media containing 10% fetal bovine serum, and then washed twice in PBS. Detached cells were pelleted by centrifugation and then resuspended in ice-cold lysis buffer (20 mM Tris [pH 7.5], 100 mM NaCl, 0.5% NP-40, 0.5 mM EDTA) in the presence of Complete Protease Inhibitors (Roche, ). Cell lysates were passed through a 25-gauge needle ten times and then resuspended in Criterion loading buffer (Bio-Rad, ). Next, 20 mug of cell lysate per sample was loaded on a Criterion XT 10% polyacrylamide gel (Bio-Rad). Following electrophoresis (at 50 amps/gel), proteins were transferred to Immobilon FL PVDF membranes (Millipore, ) and then immunostained with anti-PARP (Cell Signaling Technologies, ) and anti-rabbit 680 (Invitrogen, ) antibodies. The primary anti-PARP antibody was diluted 1:1,000 in TPBS (PBS, 0.1% Triton-X 100) plus 5% nonfat dry milk (NFDM). The secondary anti-rabbit 680 antibody was diluted 1:10,000 in TPBS plus 5% NFDM and 0.1% sodium dodecyl sulfate (SDS). Blots were incubated with secondary antibody for 1 h at 4 degreesC and then washed 5 times with TPBS. Protein bands were visualized by the Odyssey infrared system (LI-COR Biosciences, ). Protein concentrations of all samples were determined by BCA protein assay (Pierce Biotechnology, ) prior to loading.
###end p 56
###begin p 57
###xml 1134 1135 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
For all other Western blots, the above protocol was followed with the exception that secondary HRP-conjugated antibodies were diluted in TPBS plus 5% NFDM and bands were visualized by ECL detection, using ECL plus (Amersham Biosciences, ). For Bax 6A7 immunoprecipitation, cells were lysed in CHAPS buffer (10 mM HEPES, 150 mM NaCl, 1% CHAPS, protease inhibitors) on ice for 10 min, followed by ten passes through a 25-gauge needle. Then, 2 mug of Bax 6A7 monoclonal antibody (Abcam, ) was added to 1 mg of cellular protein and incubated 8 h at 4 degreesC under constant mixing followed by incubation with protein A/G beads (Santa Cruz Biotechnology, ) according to the manufacturer's protocol. Protein-bead complexes were then washed with lysis buffer 3 times, boiled for 3 min, and subject to Western blot with anti-Bax antibody (Cell Signaling Technologies) and ECL detection according to methods described above. Antibodies used were anti-ATR (obtained from Dr. Paul Nghiem, Harvard University, Boston, Massachusetts, United States), anti-GADD45 (Santa Cruz Biotechnology), anti-Bax (Cell Signaling Technologies), anti-cytochrome c (Santa Cruz Biotechnology), anti-Smac/Diablo (Imgenex Corporation, ), and Bax 6A7 (Abcam).
###end p 57
###begin title 58
Cell cycle analysis.
###end title 58
###begin p 59
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 347 348 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Cells were harvested and counted; 1 x 106 cells were aliquoted into tubes and washed once with cold PBS. Washed cells were resuspended in 0.5 ml of cold PBS, following which 2 ml of ice-cold ethanol was slowly added with gently vortexing. Ethanol-fixed cells were left overnight at -20 degreesC. The following day, cells were centrifuged at 828 x g, and ethanol was washed from the cells. Cells were then resuspended in propidium iodide staining buffer (10 mug/ml propidium iodide, 2% FBS, 11.25 kU RNase A/ml, 0.02% sodium azide) and allowed to incubate for 10 min on ice prior to analysis of DNA content by flow cytometry. Cell cycle profiles were further analyzed using Modfit software (Verity Software, ) to derive percentages of cells in different phases of cell cycle.
###end p 59
###begin title 60
Viral vectors and virus.
###end title 60
###begin p 61
###xml 193 195 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b069">69</xref>
###xml 214 216 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b070">70</xref>
###xml 262 264 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b018">18</xref>
###xml 423 424 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 519 520 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 709 710 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 713 714 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 714 715 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 717 718 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 722 723 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 731 732 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 797 798 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 798 799 784 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 862 863 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 895 896 881 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1061 1062 1047 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1561 1563 1544 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b071">71</xref>
DHIV3 and pHR lentiviral vectors were produced by transient transfection of HEK293T cells. For production of pHR vectors, pHR-VPR or pHR-VPR(R80A) was cotransfected with pCMVDeltaR8.2DeltaVPR [69], and pHCMV-VSVG [70] by calcium phosphate-mediated transfection [18]. Virus-containing supernatants were harvested at 24, 48, and 72 h post-transfection. Supernatants were cleared of cellular debris by centrifugation at 828 x g for 10 min, and virus in cleared supernatants was concentrated by centrifugation at 115,889 x g for 2 h at 4 degreesC. Virus was titered by infection of HeLa cells and subsequent flow cytometric analysis of the reporter molecule GFP. Vector titers were calculated with the equation [(F x C0)/V] x D, where F is the frequency of GFP-positive cells found by flow cytometry, C0 is the total number of target cells at the time of infection, V is the volume of inoculum, and D is the virus dilution factor. The virus dilution factor used for titrations was 10. The total number of target cells at the time of infection for titer was 0.5 x 106. Infections were performed at a multiplicity of infection (MOI) of 2.5 with 10 mug of Polybrene/ml for 8 h. Infections of siRNA-treated cells were performed 48 h after siRNA transfection. T cells and HeLa cells were transduced with virus diluted in cell culture media with 8 mug/ml and 10 mug/ml Polybrene, respectively. For HeLa cell transduction, virus-containing media was washed after 8 h and replaced with fresh culture media. T cells were transduced by spinoculation as previously described [71].
###end p 61
###begin p 62
###xml 31 36 31 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The HIV-1 molecular clone HIV-1NL4-3 was transfected into 2 x 107 HEK293FT cells by calcium phosphate transfection. At 48 h after transfection, HEK293FT cells were co-cultured with 107 MT-2 cells for 5 h. MT-2 cells were then cultured alone until approximately 75% of cell clumps showed syncitia. Virus-containing supernatants were then cleared of cells and debris by centrifugation at 2,000 rpm for 10 min. Viral stocks were then frozen at -80 degreesC. Spin infections were performed as described above.
###end p 62
###begin title 63
Apoptosis assays.
###end title 63
###begin p 64
For analysis of apoptotic nuclear morphology, cells were fixed in the well with 2% paraformaldehyde (in PBS) for 15 min at room temperature (RT). Fixed cells were then permeabilized in 0.1% Triton X-100 (in PBS) for 15 min at RT, gently washed 2 times in PBS, and then incubated in 0.5 mug/ml DAPI (Invitrogen) for 45 min at 37 degreesC. Apoptotic nuclei were identified by fluorescence microscopy, counted, and divided by total cells in the field to determine percent apoptosis. For cell counting, fields were chosen at random, and a minimum of 1,000 cells were counted per treatment in each experiment. Standard deviations were derived from three separate experiments. PARP cleavage was assayed by Western blot as described above. For analysis of caspase activity, cells were stained with FITC-VAD-FMK (Promega, ) or RED-VAD-FMK (Calbiochem/EMD Biosciences, ) according to manufacturer's protocols. Caspase-stained cells were analyzed by flow cytometry.
###end p 64
###begin p 65
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020127-b072">72</xref>
Phosphatidylserine exposure at the cell surface was analyzed as previously described [72] by flow cytometry using phycoerythrin-conjugated annexin V (Annexin V-PE, Bender MedSystems, ).
###end p 65
###begin title 66
siRNA treatments.
###end title 66
###begin p 67
###xml 56 61 <span type="species:ncbi:9606">human</span>
All siRNA treatments were performed with Dharmacon anti-human smart pool siRNA duplexes (Dharmacon, ). Smart pool siRNAs were transfected at a final concentration of 100 nM into exponentially growing HeLa cells with Oligofectamine (Invitrogen) according to the manufacturer's protocol. Cells were split 1:3 at 24 h post-transfection. At 48 h post-transfection, cells were harvested to verify knockdown by Western blot or subject to experimental treatments.
###end p 67
###begin title 68
Cell culture.
###end title 68
###begin p 69
###xml 279 280 279 280 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
For experiments in which cell synchronization or the use of siRNAs was to be employed, we used the human cervical cancer cell line HeLa, which was maintained in Dulbecco's modified Eagle's medium (Cambrex BioScience (formerly BioWhittaker), ), supplemented with 10% FCS and 2 mM l-glutamine. For experiments in which viral transduction and measurement of cell cycle/apoptosis were the aims, we used the human T-cell line SupT1, which was maintained in RPMI 1640 (Cambrex BioScience), supplemented with 10% FCS and L-glutamine.
###end p 69
###begin p 70
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 322 323 322 323 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
Peripheral blood mononuclear cells were obtained with Leukopaks from unidentified, healthy donors (American Red Cross, ), and CD4+ lymphocytes were purified using anti-CD4 magnetic beads (Dynal/Invitrogen) according to the manufacturer's instructions. CD4+ T cells were activated by culture in RPMI plus 10% FBS plus 1 mM l-glutamine with 3 anti-CD3/anti-CD28 beads per cell (Invitrogen) for 2 d, changing medium daily. After 2 d, recombinant interleukin 2 was added to the culture medium at a concentration of 100 units/ml.
###end p 70
###begin title 71
Drug treatments.
###end title 71
###begin p 72
Thymidine was diluted to a concentration of 2 mM in culture media and then added to exponentially growing HeLa cells. For experiments in which thymidine treatment was combined with viral gene expression, thymidine-containing media was added immediately following transduction. For experiments in which thymidine treatment was combined with genotoxic drugs, cells were incubated in thymidine-containing media for 4 h prior to the addition of genotoxins. Etoposide (Sigma Aldrich, ) and MNNG (Sigma Aldrich) were diluted in culture media to a concentration of 25 muM and incubated with cells for 3 h. Following incubation, genotoxin-containing media was removed and replaced with fresh media with or without thymidine.
###end p 72
###begin title 73
Supporting Information
###end title 73
###begin title 74
Accession Numbers
###end title 74
###begin p 75
###xml 185 190 181 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 180 183 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The GenBank () accession numbers for the proteins discussed in this paper are ANT (P12235 [GenPept]), ATM (NM_000051), ATR (NM_001184), BRCA1 (NP_009233), GADD45alpha (NM_001924), HIV-1NL4-3 VPR (AAB60574 [GenPept]), and VDAC (P21796 [GenPept]).
###end p 75
###begin p 76
We thank Dr. Wayne Green, Dr. Douglas Grossman, Namson Hawk, and Michael Blackwell for technical assistance and Dr. Christopher D. Freel for insight into potential Vpr interactions. We are grateful to Dr. Paul Nghiem for providing antibodies to ATR.
###end p 76
###begin title 77
Abbreviations
###end title 77
###begin p 78
adenine nucleotide transporter
###end p 78
###begin p 79
ataxia telangiectasia mutated
###end p 79
###begin p 80
ataxia and telangiectasia mutated and Rad3 related
###end p 80
###begin p 81
breast cancer-associated protein 1
###end p 81
###begin p 82
4',6-diamidino-2-phenylindole dihydrochloride
###end p 82
###begin p 83
double-strand break
###end p 83
###begin p 84
growth arrest and DNA damage-responsive protein alpha
###end p 84
###begin p 85
green fluorescent protein
###end p 85
###begin p 86
###xml 0 35 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
human immunodeficiency virus type 1
###end p 86
###begin p 87
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N&#8242;</italic>
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
N-methyl-N'-nitro-N-nitrosoguanidine
###end p 87
###begin p 88
monomeric red fluorescent protein
###end p 88
###begin p 89
poly-ADP-ribose polymerase
###end p 89
###begin p 90
permeability transition pore complex
###end p 90
###begin p 91
small interfering RNA
###end p 91
###begin p 92
second mitochondria-derived activator of caspase
###end p 92
###begin p 93
voltage-dependent anion channel
###end p 93
###begin p 94
viral protein R
###end p 94
###begin title 95
References
###end title 95
###begin article-title 96
###xml 46 49 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Viral and host factors in the pathogenesis of HIV infection
###end article-title 96
###begin article-title 97
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Apoptosis as an HIV strategy to escape immune attack
###end article-title 97
###begin article-title 98
Apoptosis in AIDS
###end article-title 98
###begin article-title 99
###xml 22 27 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
###end article-title 100
###begin article-title 101
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Viral dynamics in human immunodeficiency virus type 1 infection
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 dynamics in vivo: Implications for therapy
###end article-title 102
###begin article-title 103
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of Vpr in HIV-1 pathogenesis
###end article-title 103
###begin article-title 104
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Vpr protein from HIV-1: Distinct roles along the viral life cycle
###end article-title 104
###begin article-title 105
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells
###end article-title 106
###begin article-title 107
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo
###end article-title 107
###begin article-title 108
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R
###end article-title 108
###begin article-title 109
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation
###end article-title 109
###begin article-title 110
###xml 36 41 <span type="species:ncbi:9606">human</span>
ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses
###end article-title 110
###begin article-title 111
Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin
###end article-title 111
###begin article-title 112
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis
###end article-title 112
###begin article-title 113
###xml 79 115 <span type="species:ncbi:11726">simian immunodeficiency virus SIVagm</span>
###xml 120 155 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes
###end article-title 113
###begin article-title 114
Increased levels of Wee-1 kinase in G(2) are necessary for Vpr- and gamma irradiation-induced G(2) arrest
###end article-title 114
###begin article-title 115
###xml 48 83 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis
###end article-title 115
###begin article-title 116
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis
###end article-title 116
###begin article-title 117
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence for a cytopathogenicity determinant in HIV-1 Vpr
###end article-title 117
###begin article-title 118
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
###end article-title 118
###begin article-title 119
Permeabilization of the mitochondrial inner membrane during apoptosis: Impact of the adenine nucleotide translocator
###end article-title 119
###begin article-title 120
###xml 87 122 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
###end article-title 120
###begin article-title 121
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr induces DNA replication stress in vitro and in vivo
###end article-title 121
###begin article-title 122
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein
###end article-title 122
###begin article-title 123
Synchronization of division induced in HeLa cells with an excess of thymidine. Studies on blockage of various stages of the cell cycle
###end article-title 123
###begin article-title 124
###xml 82 117 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr
###end article-title 124
###begin article-title 125
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr
###end article-title 125
###begin article-title 126
Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase
###end article-title 126
###begin article-title 127
G2 arrest in response to topoisomerase II inhibitors: The role of p53
###end article-title 127
###begin article-title 128
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard
###end article-title 128
###begin article-title 129
Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation
###end article-title 129
###begin article-title 130
Cell death by mitotic catastrophe: A molecular definition
###end article-title 130
###begin article-title 131
UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1
###end article-title 131
###begin article-title 132
###xml 42 47 <span type="species:ncbi:9606">human</span>
Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis
###end article-title 132
###begin article-title 133
Study of PTPC composition during apoptosis for identification of viral protein target
###end article-title 133
###begin article-title 134
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
###end article-title 134
###begin article-title 135
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death
###end article-title 135
###begin article-title 136
Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis
###end article-title 136
###begin article-title 137
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death
###end article-title 137
###begin article-title 138
Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells
###end article-title 138
###begin article-title 139
DNA damage-induced apoptosis
###end article-title 139
###begin article-title 140
The Bcl-2 family: Roles in cell survival and oncogenesis
###end article-title 140
###begin article-title 141
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane
###end article-title 141
###begin article-title 142
Bid, but not Bax, regulates VDAC channels
###end article-title 142
###begin article-title 143
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis
###end article-title 143
###begin article-title 144
Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival
###end article-title 144
###begin article-title 145
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
###end article-title 145
###begin article-title 146
###xml 4 39 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle
###end article-title 146
###begin article-title 147
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B
###end article-title 147
###begin article-title 148
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
###end article-title 148
###begin article-title 149
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes
###end article-title 149
###begin article-title 150
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells
###end article-title 150
###begin article-title 151
Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation
###end article-title 151
###begin article-title 152
Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis
###end article-title 152
###begin article-title 153
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 65 70 <span type="species:ncbi:9606">child</span>
Functional conservation of HIV-1 Vpr and variability in a mother-child pair of long-term non-progressors
###end article-title 153
###begin article-title 154
Studies with GFP-Vpr fusion proteins: Induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization
###end article-title 154
###begin article-title 155
Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks
###end article-title 155
###begin article-title 156
Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis
###end article-title 156
###begin article-title 157
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53
###end article-title 157
###begin article-title 158
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
###end article-title 158
###begin article-title 159
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells
###end article-title 159
###begin article-title 160
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr
###end article-title 160
###begin article-title 161
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock
###end article-title 161
###begin article-title 162
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection?
###end article-title 162
###begin article-title 163
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo
###end article-title 163
###begin article-title 164
###xml 13 48 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication
###end article-title 164
###begin article-title 165
###xml 54 89 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 131 157 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
###end article-title 165
###begin article-title 166
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
###end article-title 166
###begin article-title 167
Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway
###end article-title 167
###begin title 168
Figures and Tables
###end title 168
###begin title 169
###xml 109 110 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Vpr-Induced Caspase Activation and Smac Release from the Mitochondria Are Temporally Delayed in Relation to G2 Arrest
###end title 169
###begin p 170
###xml 80 85 80 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr,</italic>
###xml 351 356 351 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4&#8211;3</sub>
###xml 437 440 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 75 78 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 346 349 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) pHR-VPR-G and pHR-VPR-R are bicistronic lentiviral vectors that encode HIV-1NL4-3vpr, an internal ribosome entry site, and either the gene for GFP or that for mRFP, respectively; pHR-VPR(R80A) was derived from pHR-VPR (both the mRFP and the GFP versions) by site-directed mutagenesis; DHIV3 is an envelope-truncated (see gray box) version of HIV-1NL4-3; DHIV3-DeltaVPR was derived from DHIV-3 by introducing a frameshift mutation in vpr.
###end p 170
###begin p 171
(B) SupT1 T lymphocytes were transduced by spin-infection in the presence of 10 mug/ml Polybrene with indicated vectors. Mock-infected cells were subjected to spin-infection in the presence of 10 mug/ml Polybrene without virus. Cells were collected at specified time points post-transduction, stained with propidium iodide, and analyzed for DNA content by flow cytometry to determine cell cycle profiles. The percentage of cells transduced with pHR vectors and DHIV3 viruses ranged between 70% to 80% and between 65% to 70%, respectively, as determined by mRFP or GFP expression (with pHR vectors) or intracellular p24 staining (with DHIV3 vectors).
###end p 171
###begin p 172
(C) Caspase activation was measured as an indication of apoptosis. SupT1 cells were infected with indicated vectors, harvested, and incubated with FITC-VAD-FMK. The percentage of caspase-active cells at each time point was measured by flow cytometry.
###end p 172
###begin p 173
(D) Infected SupT1 cells were lysed, and lysates were fractionated into mitochondrial (m) and cytoplasmic (c) fractions and then assayed by Western blot. Western blots were probed with antibodies specific to Smac to measure release from mitochondria and with anti-VDAC antibodies to measure mitochondrial contamination in the cytoplasmic fractions. As a positive control for apoptosis, SupT1 cells were treated with 0.8 mug/ml doxorubicin (dox) for 48 h.
###end p 173
###begin p 174
(E) Examples of flow cytometric analysis of caspase activation, corresponding to the 72-h time points from (C).
###end p 174
###begin title 175
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
The Apoptotic Effect of Vpr Is Lost in Cells Synchronized in G1/S
###end title 175
###begin p 176
###xml 258 259 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 267 268 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) HeLa cells were transduced with pHR-VPR-G or mock-transduced and then incubated with 2 mM thymidine. After 24 h of incubation, cells were harvested, stained with PI, and analyzed for DNA content by flow cytometry to determine the percentage of cells in G1/S and G2/M. Transduction efficiency of pHR-VPR in both thymidine-treated and cycling cells was 70% to 75% as determined by analysis of GFP expression by flow cytometry (unpublished data).
###end p 176
###begin p 177
(B) Cells from experiments shown in (A) were stained for DAPI at 72 h postinfection, in order to evaluate apoptosis via chromatin morphology
###end p 177
###begin p 178
(C) Quantitation of apoptosis in DAPI-stained samples shown in (B); incubation with 25 muM etoposide for 48 h or 1 muM staurosporine for 8 h was included in both cycling and thymidine-treated cells, for comparative purposes.
###end p 178
###begin p 179
(D) Cycling or thymidine-synchronized HeLa cells were mock-transduced or transduced with either pHR-VPR-R or pHR-VPR(R80A) for apoptosis analysis, using FITC-VAD-FMK. As positive controls for apoptosis, cycling and synchronized cells were treated with etoposide or staurosporine as shown in (C).
###end p 179
###begin p 180
(E) Cycling or thymidine-synchronized HeLa cells expressing Vpr or treated with 25 muM etoposide for 48 h were lysed and analyzed by Western blot for PARP cleavage as a marker of apoptosis/caspase activity. The caspase-cleaved PARP band is observed at 89 kDa.
###end p 180
###begin p 181
(F) Cell lysates from pHR-VPR-transduced cells, with or without thymidine block, were harvested at 12 and 24 h post-transduction and analyzed by Western blot for Vpr expression with antibodies specific to the amino-terminal hemagglutinin tag.
###end p 181
###begin title 182
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Release of Vpr-Expressing Cells from Thymidine Block Leads to Reentry into the Cell Cycle and Vpr-Induced, G2-Dependent Apoptosis
###end title 182
###begin p 183
(A) Thymidine-synchronized HeLa cells transduced with pHR-VPR-G or mock-transduced were released from thymidine block and harvested at specified time points postrelease. Cells from each time point were stained with PI and analyzed for DNA content by flow cytometry.
###end p 183
###begin p 184
(B) pHR-VPR-transduced HeLa cells from the same experiment were monitored by Western blot for PARP cleavage at specified time points. Time points labeled under "Thym + pHR-VPR" indicate hours following release from thymidine block; time points under "pHR-VPR" indicate hours following transduction, as these cells were not synchronized.
###end p 184
###begin p 185
(C) Cells treated as those in (A) and (B) were harvested at 24 and 48 h were analyzed for apoptosis by DAPI staining, and the results are quantified.
###end p 185
###begin title 186
siRNA-Mediated Knockdown of ATR or Bax, but Not of ANT, Suppresses Vpr-Induced Apoptosis
###end title 186
###begin p 187
###xml 463 471 461 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020127-g002">Figure 2</xref>
(A) HeLa cells were transfected with nonspecific (NS) siRNA or siRNA targeted to ATR, or ATM as indicated. At 48 h post-transfection, cells were either treated with 25 muM etoposide, treated with 25 muM MNNG, mock-transduced, or transduced with pHR-VPR-R. Additionally, cells transfected with siRNAs targeted to Bax or ANT were transduced with pHR-VPR-R or mock-transduced (lower left dot plots). Cells from each treatment were assayed for caspase activity as in Figure 2B.
###end p 187
###begin p 188
(B) Cells treated as in (A) were harvested at specified time points post-transduction and assayed for caspase activity.
###end p 188
###begin p 189
(C) Cells treated as in (A) were stained with DAPI, and the results were quantified by microscopy.
###end p 189
###begin p 190
(D) Cells treated with the indicated siRNAs were lysed and analyzed by Western blot to verify knockdown efficiency.
###end p 190
###begin p 191
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 17 <span type="species:ncbi:9606">human</span>
(E) Primary human CD4+ lymphocytes were infected with DHIV3, infected with DHIV3DeltaVPR, or mock-infected. At 48 h postinfection, cells in each treatment were lysed and assayed for protein concentration. Equal amounts of protein from each treatment were incubated with Bax6A7 monoclonal antibody. Antibody-protein complexes were precipitated with agarose beads and boiled and then subjected to Western blot analysis with a polyclonal antibody to Bax.
###end p 191
###begin p 192
(F) HeLa cells treated with the indicated siRNAs and transduced with pHR-VPR or mock-transduced were lysed; reactivity to Bax6A7 antibody was assayed as described in (E).
###end p 192
###begin title 193
Vpr Induces Histone 3 Phosphorylation in HeLa but Not in SupT1 Cells
###end title 193
###begin p 194
HeLa or Supt1 cells were transduced with pHR-VPR-G and at indicated time points, lysed, and analyzed by Western blot with a phospho-specific antibody that recognizes phosphorylation of H3 at serine-10. Nocodazole (250 ng/ml) and doxorubicin (1 muM) were used as positive and negative controls, respectively.
###end p 194
###begin title 195
Functional Analysis of Vpr Mutants
###end title 195
###begin p 196
(A) SupT1 cells were infected with pHR-VPR-R or indicated mutants, at an MOI of 0.5. At 48 h postinfection, cells were stained with hypotonic PI to determine the cell cycle profiles. At 72 h postinfection, cells were incubated with FITC-VAD-FMK and analyzed by flow cytometry to determine the percentage of cells with active caspases.
###end p 196
###begin p 197
(B) Cells from above treatments were lysed at 48 h postinfection, and Western blot was performed to assay for phosphorylation of BRCA1 at Ser1423 by the ATR kinase. To establish the role of ATR in BRCA1 phosphorylation, parallel infections were treated with caffeine (2 mM).
###end p 197
###begin p 198
(C) Induction of apoptosis by Vpr-GFP and Vpr(R80A)-GFP fusion proteins. HPB-ALL cells were transfected with indicated constructs or mock-transfected and 48 after transfection, phosphatidylserine exposure was analyzed by flow cytometry using phycoerythrin-conjugated annexin V.
###end p 198
###begin title 199
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Models to Explain the Activities of HIV-1 Vpr
###end title 199
###begin p 200
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 199 200 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A). Activation of ATR by Vpr and downstream signaling consequences leading to both G2 arrest and apoptosis. The functional link between GADD45alpha and activation of Bax and the mechanism by which G2 arrest leads to Bax activation remain unknown (question marks).
###end p 200
###begin p 201
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
(B) Binding of Vpr to mitochondrial PTPC was proposed to trigger release of cytochrome c and induction of apoptosis, independently of cell cycle status; in this work, we propose that an alternative pore-forming mitochondrial protein, Bax, is the effector of Vpr-induced apoptosis, and that Bax activation requires upstream stress signals derived from ATR.
###end p 201
###begin p 202
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 202
###begin p 203
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. JLA, GJ, SB, and VP conceived and designed the experiments. JLA, JLD, GJ, and SB performed the experiments. JLA, JLD, GJ, SB, and VP analyzed the data. JLA, JLD, ESZ, OA, BK, and VP contributed reagents/materials/analysis tools. JLA and VP wrote the paper.
###end p 203
###begin p 204
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This research was supported by National Institutes of Health (NIH) research grant AI49057 to VP. JLA is supported by NIH Training Grant in Microbial Pathogenesis T32 AI055434. ESZ is supported by NIH Genetics Training Grant T32 GM07464.
###end p 204

